Kollmer, Holger and Dowling, Michael (2004) Licensing as a commercialisation strategy for new technology-based firms. RESEARCH POLICY, 33 (8). pp. 1141-1151. ISSN 0048-7333, 1873-7625
Full text not available from this repository. (Request a copy)Abstract
We investigate licensing as a commercialisation strategy for new technology-based firms (NTBFs) in the biopharmaceutical industry using a combination of survey and database research methods. We found that most firms in our sample were not fully integrated regardless of their company age which is consistent with the picture of NTBFs as agents of technology transfer. Comparing fully and not-fully integrated firms we find differences in the use of licensing strategies. According to Ford and Ryan [Harvard Business Review 59 (1981) 117] fully integrated companies apply licensing for strategic reasons and for financially unattractive projects. Our results provide partial support for this theory. (C) 2004 Elsevier B.V. All rights reserved.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | BIOTECHNOLOGY INDUSTRY; INNOVATION; COLLABORATION; INTEGRATION; PERFORMANCE; ALLIANCES; NETWORKS; licensing strategy; technology-based firms; technology transfer; biotech industry |
| Subjects: | 600 Technology > 650 Management & auxiliary services |
| Divisions: | Business, Economics and Information Systems > Institut für Betriebswirtschaftslehre > Lehrstuhl für Innovations- und Technologiemanagement (Prof. Dr. Michael Dowling) |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 28 Jun 2021 08:33 |
| Last Modified: | 28 Jun 2021 08:33 |
| URI: | https://pred.uni-regensburg.de/id/eprint/37168 |
Actions (login required)
 |
View Item |
